ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,437Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 36

$623K Total Retail Price of All Prescriptions

Rank: 7 out of 36

217 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 217 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 217 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 9,043 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 367 361 1 3
NAMENDA 362 362 2 10
OMEPRAZOLE 328 326 3 7
WARFARIN SODIUM 290 288 4 5
AMLODIPINE BESYLATE 257 245 5 6
MIRTAZAPINE 244 239 6 23
DONEPEZIL HCL 238 226 7 9
LISINOPRIL 237 217 8 2
CYMBALTA 228 226 9 33
ALBUTEROL SULFATE 224 223 10 51
POLYETHYLENE GLYCOL 3350 206 199 11 32
METOPROLOL TARTRATE 200 185 12 8
POTASSIUM CHLORIDE 179 171 13 17
FUROSEMIDE 156 154 14 4
PREDNISONE 146 146 15 31
HYDROCODONE-ACETAMINOPHEN 134 134 S3 16 11
ESCITALOPRAM OXALATE 130 128 17 28
TRAZODONE HCL 128 113 18 15
BACLOFEN 126 124 19 70
TRAMADOL HCL 126 126 19 20
LEVETIRACETAM 124 108 21 45
GLIPIZIDE 121 120 22 55
SIMVASTATIN 120 120 23 1
ADVAIR DISKUS 102 101 24 54
BUMETANIDE 101 97 25 153
PANTOPRAZOLE SODIUM 100 100 26 48
LIDODERM 92 91 27 43
RISPERIDONE 90 77 28 30
NEXIUM 88 83 29 46
CARVEDILOL 80 75 30 26
KLOR-CON M20 77 77 31 38
CARBIDOPA-LEVODOPA 75 69 32 64
GABAPENTIN 74 72 33 12
TAMIFLU 74 71 33 167
CITALOPRAM HBR 72 72 35 14
DIVALPROEX SODIUM 67 57 36 59
IPRATROPIUM-ALBUTEROL 66 65 37 46
SANTYL 66 66 37 88
LEVOFLOXACIN 64 62 39 92
LANTUS 62 58 40 27
JANTOVEN 61 61 41 65
QUETIAPINE FUMARATE 60 59 42 19
METOPROLOL SUCCINATE 60 58 42 24
FAMOTIDINE 56 56 44 39
FLUTICASONE PROPIONATE 56 55 44 53
DIGOXIN 55 55 46 56
CIPROFLOXACIN HCL 50 46 47 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.